While initial reports of iNOS inhibition in animal models of acute arthritis were promising [27, 28], clinical trials of selective iNOS inhibitors in early RA patients failed to demonstrate significant efficacy [29]. This evidence concerns the gene NOS2 and rheumatoid arthritis.